Costa Mesa drug maker Valeant Pharmaceuticals International plans to forge ahead with development of a key hepatitis C treatment, even after a critical clinical trial came up short and an analyst said the "drug is dead...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to OCBJ.com archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99